Aline Clavert

1.6k total citations
23 papers, 225 citations indexed

About

Aline Clavert is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Aline Clavert has authored 23 papers receiving a total of 225 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Pathology and Forensic Medicine and 8 papers in Genetics. Recurrent topics in Aline Clavert's work include Lymphoma Diagnosis and Treatment (10 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (6 papers). Aline Clavert is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Hematopoietic Stem Cell Transplantation (7 papers) and Acute Myeloid Leukemia Research (6 papers). Aline Clavert collaborates with scholars based in France, Spain and Belgium. Aline Clavert's co-authors include Mohamad Mohty, Jacques Delaunay, Éolia Brissot, Béatrice Gaugler, Patrice Chevallier, Marc Grégoire, Viviane Dubruille, Beatrice Mahé, Philippe Moreau and Steven Le Gouill and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Transplantation.

In The Last Decade

Aline Clavert

20 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aline Clavert France	10	125	86	55	54	51	23	225
Sujaatha Narayanan Canada	10	181 1.4×	81 0.9×	61 1.1×	63 1.2×	40 0.8×	43	272
Rocco Pastano Italy	10	177 1.4×	74 0.9×	66 1.2×	64 1.2×	33 0.6×	19	285
Andres Virchis United Kingdom	10	95 0.8×	90 1.0×	89 1.6×	65 1.2×	34 0.7×	15	285
Laura Gallur Spain	6	184 1.5×	69 0.8×	55 1.0×	83 1.5×	38 0.7×	18	266
Eduardo Ríos Spain	10	70 0.6×	73 0.8×	77 1.4×	109 2.0×	56 1.1×	32	221
E. Alyea United States	8	192 1.5×	102 1.2×	71 1.3×	77 1.4×	117 2.3×	14	300
Claudia Minotto Italy	9	92 0.7×	122 1.4×	62 1.1×	110 2.0×	58 1.1×	14	252
Elena Maino Italy	8	102 0.8×	67 0.8×	66 1.2×	92 1.7×	18 0.4×	15	230
Sara Barulli Italy	7	110 0.9×	117 1.4×	54 1.0×	97 1.8×	51 1.0×	12	274
Silvia Imbergamo Italy	10	83 0.7×	119 1.4×	44 0.8×	62 1.1×	60 1.2×	20	224

Countries citing papers authored by Aline Clavert

Since Specialization

Citations

This map shows the geographic impact of Aline Clavert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aline Clavert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aline Clavert more than expected).

Fields of papers citing papers by Aline Clavert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aline Clavert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aline Clavert. The network helps show where Aline Clavert may publish in the future.

Co-authorship network of co-authors of Aline Clavert

This figure shows the co-authorship network connecting the top 25 collaborators of Aline Clavert. A scholar is included among the top collaborators of Aline Clavert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aline Clavert. Aline Clavert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cartron, Guillaume, Emmanuel Bachy, Hervé Tilly, et al.. (2022). Subcutaneous rituximab induction followed by short rituximab maintenance to improve progression-free survival in patients with low-tumor burden follicular lymphoma: Final results of FLIRT phase III trial, a LYSA study.. Journal of Clinical Oncology. 40(16_suppl). 7512–7512. 1 indexed citations

Mercier, Mélanie, Corentin Orvain, Laurianne Drieu La Rochelle, et al.. (2021). Impact of High-Dose Methotrexate on the Outcome of Patients with Diffuse Large B-Cell Lymphoma and Skeletal Involvement. Cancers. 13(12). 2945–2945.

Régny, Caroline, Lucie Obéric, Sandra Malak, et al.. (2019). PF482 CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP. HemaSphere. 3(S1). 193–193. 1 indexed citations

Farhi, Jonathan, Kamel Laribi, Corentin Orvain, et al.. (2018). Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma. Annals of Hematology. 97(12). 2391–2401. 14 indexed citations

Jaccard, Arnaud, Jean‐François Benoist, Lucile Couronné, et al.. (2018). Monitoring Asparaginase Activity in 21 Patients with Extranodal NK/T-Cell Lymphoma Shows a Very High Proportion of Asparaginase Inactivation. Blood. 132(Supplement 1). 5351–5351. 1 indexed citations

Clavert, Aline, Zinaida Perić, Éolia Brissot, et al.. (2016). Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 23(1). 140–146. 22 indexed citations

Gauthier, Jordan, Gandhi Damaj, Carole Langlois, et al.. (2015). Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes. Transplantation. 99(8). 1672–1680. 6 indexed citations

Lacout, Carole, Aline Clavert, Jonathan Farhi, et al.. (2015). R-DHA-Oxaliplatin Versus R-DHA-Cisplatin Regimen in B-Cell Nhl's Treatment: A Eight Years Retrospective Study. Blood. 126(23). 3959–3959. 1 indexed citations

Cahu, Xavier, Patrice Chevallier, Aline Clavert, et al.. (2014). Allo-SCT for Philadelphia-negative myeloproliferative neoplasms in blast phase: a study from the Societe Française de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC). Bone Marrow Transplantation. 49(6). 756–760. 31 indexed citations

10.

Clavert, Aline, Martine Gardembas, Martine Escoffre‐Barbe, et al.. (2014). A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial. American Journal of Hematology. 89(11). 1024–1029. 17 indexed citations

11.

Bourgeois, Amandine Le, Thierry Guillaume, Jacques Delaunay, et al.. (2013). Prognostic impact of immune status and hematopoietic recovery before and after fludarabine, IV busulfan, and antithymocyte globulins (FB2 regimen) reduced‐intensity conditioning regimen (RIC) allogeneic stem cell transplantation (allo‐SCT). European Journal Of Haematology. 90(3). 177–186. 15 indexed citations

12.

Touzeau, Cyrille, Nicolas Blin, Aline Clavert, et al.. (2012). Efficacy of lenalidomide plus dexamethasone in patients older than 75 years with relapsed multiple myeloma. Leukemia & lymphoma. 53(7). 1318–1320. 8 indexed citations

13.

Péterlin, Pierre, Christophe Leux, Thomas Gastinne, et al.. (2012). Is ASCT With TBI Superior to ASCT Without TBI in Mantle Cell Lymphoma Patients?. Transplantation. 94(3). 295–301. 10 indexed citations

14.

Guillaume, Thierry, Béatrice Gaugler, Patrice Chevallier, et al.. (2011). Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity. Bone Marrow Transplantation. 47(8). 1112–1117. 19 indexed citations

15.

Clavert, Aline, Jacques Delaunay, Éolia Brissot, et al.. (2011). Impact of the hypomethylating agent 5-azacytidine on dendritic cells function. Experimental Hematology. 39(11). 1056–1063. 47 indexed citations

16.

Malard, Florent, Xavier Cahu, Aline Clavert, et al.. (2011). Fludarabine, Antithymocyte Globulin, and Very Low-Dose Busulfan for Reduced-Intensity Conditioning before Allogeneic Stem Cell Transplantation in Patients with Lymphoid Malignancies. Biology of Blood and Marrow Transplantation. 17(11). 1698–1703. 16 indexed citations

17.

Clavert, Aline, Xavier Cahu, Patrice Chevallier, et al.. (2011). Long-Term Complications (LTC) and Quality of Life (QOL) After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT),. Blood. 118(21). 4100–4100. 1 indexed citations

18.

Ayari, Sameh, Patrice Chevallier, Thierry Guillaume, et al.. (2011). 5-Azacytidine (AZA) Compared to Intensive Chemotherapy in Elderly Acute Myeloid Leukemia (AML) Patients: Results of a Retrospective Single Centre Matched Analysis,. Blood. 118(21). 3620–3620. 2 indexed citations

19.

Clavert, Aline, Steven Le Gouill, Éolia Brissot, et al.. (2010). Reduced-intensity conditioning allogeneic stem cell transplant for relapsed or transformed aggressive B-cell non-Hodgkin lymphoma. Leukemia & lymphoma. 51(8). 1502–1508. 9 indexed citations

20.

Baruthio, F, et al.. (1967). [Perfusions of isolated intestine in dogs. Description of a technic. Its value].. PubMed. 161(12). 2624–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact